Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a dangerous type of belly fat.
Source :- Markets-Economic Times Read More
US Stocks: Wave Life Sciences shares plunge 58% as data for high dose of obesity drug disappoints
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
